Total Payments
$56,560
2024 Payments
$7,005
Companies
40
Transactions
486
Medicare Patients
4,477
Medicare Billing
$524,476
Payment Breakdown by Category
Other$43,663 (77.2%)
Food & Beverage$12,648 (22.4%)
Travel$212.50 (0.4%)
Education$37.24 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,663 | 32 | 73.7% |
| Food and Beverage | $12,648 | 450 | 22.4% |
| Honoraria | $2,000 | 1 | 3.5% |
| Travel and Lodging | $212.50 | 1 | 0.4% |
| Education | $37.24 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $40,632 | 104 | $0 (2024) |
| Medtronic Vascular, Inc. | $4,970 | 42 | $0 (2020) |
| Medicure Pharma Inc. | $2,500 | 1 | $0 (2017) |
| Medtronic, Inc. | $1,732 | 30 | $0 (2024) |
| Amgen Inc. | $977.42 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $913.60 | 45 | $0 (2024) |
| PFIZER INC. | $874.02 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $500.81 | 30 | $0 (2024) |
| ABIOMED | $444.14 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $411.13 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,005 | 57 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($5,619) |
| 2023 | $2,729 | 39 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($1,616) |
| 2022 | $3,914 | 53 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($2,717) |
| 2021 | $7,702 | 61 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($6,517) |
| 2020 | $8,533 | 45 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($7,940) |
| 2019 | $8,320 | 68 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($7,379) |
| 2018 | $7,649 | 72 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($6,521) |
| 2017 | $10,709 | 91 | Medtronic Vascular, Inc. ($4,414) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 3 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: Cardiovascular | ||||||
| 02/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Not Applicable | ||||||
| 02/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiology | ||||||
| 01/24/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Renal Denervation System | ||||||
| 01/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Not Applicable | ||||||
| 01/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/07/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2023 | Abbott Laboratories | JETI (Device) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Vascular | ||||||
| 11/09/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Stents | ||||||
| 11/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2023 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $29.05 | General |
| Category: Peripheral Intervention | ||||||
| 10/18/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: Not Applicable | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.46 | General |
| 10/10/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology | ||||||
| 10/05/2023 | Medtronic, Inc. | TELESCOPE (Device) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Catheters | ||||||
| 09/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiology | ||||||
| 07/28/2023 | ShockWave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $114.70 | General |
| Category: Lithoplasty | ||||||
| 07/27/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Stents | ||||||
| 07/10/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $161.09 | General |
| Category: Stents | ||||||
| 06/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,157 | 1,620 | $418,448 | $119,553 |
| 2022 | 15 | 1,151 | 1,537 | $465,771 | $131,602 |
| 2021 | 16 | 1,083 | 1,466 | $540,142 | $145,509 |
| 2020 | 16 | 1,086 | 1,421 | $480,134 | $127,812 |
Total Patients
4,477
Total Services
6,044
Medicare Billing
$524,476
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 41 | 48 | $86,400 | $26,271 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 166 | 332 | $98,160 | $25,747 | 26.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 83 | 88 | $77,440 | $19,924 | 25.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 419 | 476 | $52,360 | $16,377 | 31.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 65 | $24,328 | $7,190 | 29.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 78 | $17,100 | $5,639 | 33.0% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $12,780 | $3,252 | 25.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 19 | 19 | $8,990 | $2,908 | 32.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 47 | 47 | $8,930 | $2,750 | 30.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 178 | 360 | $7,200 | $2,474 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $6,310 | $1,916 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $6,080 | $1,567 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 14 | $5,980 | $1,537 | 25.7% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 14 | 14 | $3,080 | $973.56 | 31.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 17 | 17 | $1,870 | $541.92 | 29.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 16 | 16 | $1,440 | $486.72 | 33.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 103 | 109 | $102,460 | $24,868 | 24.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 33 | 40 | $76,800 | $24,394 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 141 | 271 | $76,510 | $22,422 | 29.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 482 | 538 | $75,858 | $19,733 | 26.0% |
| 92941 | Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | Facility | 2022 | 24 | 25 | $54,000 | $17,881 | 33.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 49 | 51 | $19,890 | $5,843 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 37 | 40 | $16,910 | $4,551 | 26.9% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 20 | 21 | $15,514 | $3,074 | 19.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 167 | 331 | $6,620 | $2,357 | 35.6% |
About Dr. Bilal Malik, MD
Dr. Bilal Malik, MD is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619926375.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bilal Malik, MD has received a total of $56,560 in payments from pharmaceutical and medical device companies, with $7,005 received in 2024. These payments were reported across 486 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,663).
As a Medicare-enrolled provider, Malik has provided services to 4,477 Medicare beneficiaries, totaling 6,044 services with total Medicare billing of $524,476. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Brooklyn, NY
- Active Since 05/09/2006
- Last Updated 10/29/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1619926375
Products in Payments
- LifeVest (Device) $40,632
- Resolute (Device) $5,149
- Aggrastat (tirofiban HCl) (Drug) $2,500
- BRILINTA (Drug) $815.75
- ELIQUIS (Drug) $805.66
- Corlanor (Drug) $518.44
- XARELTO (Drug) $500.81
- ONYX FRONTIER (Device) $479.18
- Impella (Device) $444.14
- Repatha (Biological) $424.77
- COREVALVE EVOLUT R (Device) $336.16
- ENTRESTO (Drug) $271.87
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $237.95
- VERQUVO (Drug) $189.10
- INTELLIS ADAPTIVESTIM (Device) $170.39
- RESOLUTE ONYX (Device) $169.53
- CoreValve Evolut (Device) $161.51
- Xience V coronary stent system (Device) $143.10
- Arcalyst (Drug) $142.73
- PROCLAIM (Device) $142.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799